APA (7th ed.) Citation

D, M., MP, J., MP, L., K, R., IL, v. S., AM, S., . . . EM, B. (2009). TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. Breast cancer research and treatment, 113(2), 253. https://doi.org/10.1007/s10549-008-9934-3

Chicago Style (17th ed.) Citation

D, Meijer, et al. "TSC22D1 and PSAP Predict Clinical Outcome of Tamoxifen Treatment in Patients with Recurrent Breast Cancer." Breast Cancer Research and Treatment 113, no. 2 (2009): 253. https://doi.org/10.1007/s10549-008-9934-3.

MLA (9th ed.) Citation

D, Meijer, et al. "TSC22D1 and PSAP Predict Clinical Outcome of Tamoxifen Treatment in Patients with Recurrent Breast Cancer." Breast Cancer Research and Treatment, vol. 113, no. 2, 2009, p. 253, https://doi.org/10.1007/s10549-008-9934-3.